万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://onlinelibrary.wiley.com/journal/14765829
3、投稿网址：http://mc.manuscriptcentral.com/vco
4、官网邮箱：vcooffice@wiley.com（编辑部）
stefano.comazzi@unimi.it（编辑）
dthamm@colostate.edu（编辑）
5、期刊刊期：季刊，逢季末月出版。
2021年6月16日星期三
投稿须知【官网信息】
Author Guidelines
1. SUBMISSION
Thank you for your interest in Veterinary and Comparative Oncology. Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting on symposium.
Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/vco.
Please note that we also follow the recommendations set out by the International Committee of Medical Journal Editors (ICJME). For more information, visit their website at http://www.icmje.org/journals-following-the-icmje-recommendations/.
The submission system will prompt you to use an ORCiD (a unique author identifier) to help distinguish your work from that of other researchers. Click here to find out more.
Click here for more details on how to use ScholarOne.
For help with submissions, please contact: vcooffice@wiley.com
We look forward to your submission.
Data Protection and Privacy
By submitting a manuscript to, or reviewing for, this publication, your name, email address, institutional affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
Preprint Policy
Veterinary and Comparative Oncology will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
2. AIMS AND SCOPE
Veterinary and Comparative Oncology (VCO) is an international, peer-reviewed journal integrating clinical and scientific information from a variety of related disciplines and from worldwide sources for all veterinary oncologists and cancer researchers concerned with aetiology, diagnosis and clinical course of cancer in domestic animals and its prevention. With the ultimate aim of diminishing suffering from cancer, the journal supports the transfer of knowledge in all aspects of veterinary oncology, from the application of new laboratory technology to cancer prevention, early detection, diagnosis and therapy. In addition to original articles, the journal publishes solicited editorials, review articles, commentary, correspondence and abstracts from the published literature. Accordingly, studies describing laboratory work performed exclusively in purpose-bred domestic animals (e.g. dogs, cats, horses) will not be considered. Current editorial policy has been to administratively decline to publish case reports or small retrospective case series unless the information contained therein will change the standard of care for therapy, diagnosis, or investigation of the tumour in question. From time to time, VCO may publish themed issues to cover areas of importance or debate, e.g. the management of a specific tumour type, or tumour-associated condition.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Veterinary and Comparative Oncology publishes a number of different article types including:
• Original Research
Original articles should contain reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Original articles should be no more than 4,000 words, excluding references.
• Reviews
Reviews should be critical reviews of the literature, including systematic reviews and meta-analyses and should not exceed 6,000 words, excluding references.
• Short Communications
Short communications may be published more rapidly than original articles. They should be a short report of new research findings and should be no more than 2,000 words, excluding references.
• Editorials
Editorials are usually commissioned but unsolicited material may be considered. Please approach the Editorial Office (vcooffice@wiley.com) before submitting this material. Editorials have a limit of 1,000 words.
• Letters to the Editor
Letters to the Editor are welcomed and should not exceed 500 words.
• Pilot Studies
Manuscripts entitled “pilot studies” or “preliminary studies” submitted to Veterinary and Comparative Oncology must include the following information: a statement detailing how the data will be used in subsequent studies; OR a power calculation for the follow-up study; OR confirmation that a follow-up study is forthcoming. Submissions which do not include any of this information will be rejected from further consideration.
4. PREPARING YOUR SUBMISSION
Manuscripts must be submitted as a Word or rtf file and should be written in English. The manuscript should be submitted in separate files: title page; main text file; figures.
Title page
The title page should contain:
(i) a short informative title that contains the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
(ii) a short running title of less than 40 characters;
(iii) the full names of the authors;
(iv) the author's institutional affiliations at which the work was carried out;
(v) acknowledgements.
The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
Authorship
Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.
Acknowledgements
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. See section on Authorship for more detail. Financial and material support should also be mentioned Thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement You will be asked to disclose conflicts of interest during the submission process. See the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section for details on what to include in this section. Please ensure that you liaise with all co-authors to confirm agreement with the final statement. The Conflict of Interest statement should be included within the main text file of your submission.
Conflict of Interest Statement
You will be asked to provide a conflict of interest statement during the submission process. See the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section for details on what to include in this section. Please ensure you liaise with all co-authors to confirm agreement with the final statement.
Cell Line Validation Statement
VCO strongly encourages authors to validate all cell lines used in the research submitted to the journal. All original research submissions must include a cell line validation statement even if validation testing has not been conducted (i.e. a null statement). VCO requests that authors detail what validation testing they have conducted, if any, in their validation statement. If validation testing has not been conducted, the reasons for this should be clearly stated in the validation statement. This statement should be provided in the Materials and Methods section of your manuscript under the heading, ‘Cell Line Validation Statement’.
Main Text
As papers are double-blind peer reviewed the main text file should not include any information that might identify the authors.
The main text file should be presented in the following order: (i) title, author information, disclaimers, source(s) of support, word count, number of figures and tables, conflict of interest declaration, (ii) abstract and key words, (iii) introduction, (iv) methods, (v) results (vi) discussion, (vii) references, (viii) tables, (ix) illustrations (figures). Figures and supporting information should be supplied as separate files.
For further guidance on the content and style of the introduction, materials and methods, results and discussion, please follow the International Committee of Medical Journal Editors (ICJME) Uniform Requirements for Manuscripts Submitted to Biomedical Journals: http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html
Editorials, Short Communications and Letters to the Editor should be written in continuous prose with appropriate references, figures and tables as required.
Abstract
Please provide an abstract of no more than 250 words.
Keywords
Please provide 3-6 keywords and list them in alphabetical order. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at https://www.nlm.nih.gov/mesh/.
References
All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. For more information about AMA reference style please consult this guide, or the AMA Manual of Style website.
Sample references follow:
Journal Article (1-6 authors)
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.
Journal Article (more than 6 authors)
2. Barrett LE, Skorupski K, Brown DC, et al. Outcome following treatment of feline gastrointestinal mast cell tumours. Vet Comp Oncol 2018;16(2):188-193.
Entire Book
3. McKenzie BC. Medicine and the Internet: Introducing Online Resources and Terminology. 2nd ed. New York, NY: Oxford University Press; 1997.
Book Chapter
4. Guyton JL, Crockarell JR. Fractures of acetabulum and pelvis. In: Canale ST, ed. Campbell's Operative Orthopaedics. 10th ed. Philadelphia, PA: Mosby, Inc; 2003:2939-2984.
Internet Document
5. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf Accessed March 3, 2003
Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Preparing Figures
Although we encourage authors to send us the highest-quality figures possible, for peer-review purposes we are happy to accept a wide variety of formats, sizes, and resolutions.
Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
Colour figures: Figures submitted in colour may be reproduced in colour online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white. If you wish to have figures printed in colour in hard copies of the journal, a fee will be charged by the Publisher.
Please submit a Colour Work Agreement Form if figure should be colour in print.
Please post or courier your completed form to:
Customer Services (OPI)
John Wiley & Sons Ltd,
European Distribution Centre
New Era Estate
Oldlands Way
Bognor Regis
West Sussex PO22 9NQ
Appendices
Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text. Supporting Information
Supporting Information
Supporting information is information that is not essential to the article but that provides greater depth and background. It is hosted online, and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on supporting information.
Note, if data, scripts or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
General Style Points
The following links provide general advice on formatting and style.
• Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
• Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.
• Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Editorial Review and Acceptance
The acceptance criteria for all papers is the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. Wiley's policy on confidentiality of the review process is available here.
Revised manuscripts must be uploaded within one month of authors being notified of conditional acceptance pending satisfactory revision. Locate your manuscript under 'Manuscripts with Decisions' and click on 'Submit a Revision' to submit your revised manuscript. Please include a POINT BY POINT response to reviewers as part of your revised submission. In addition, please upload a revised version of your manuscript with changes clearly highlighted. Please remember to delete any old files uploaded when you upload your revised manuscript.
Data Sharing and Data Accessibility
Veterinary and Comparative Oncology recognizes the many benefits of archiving research data. The journal expects you to archive all the data from which your published results are derived in a public repository. The repository that you choose should offer you guaranteed preservation (see the registry of research data repositories at https://www.re3data.org/) and should help you make it findable, accessible, interoperable, and re-useable, according to FAIR Data Principles (https://www.force11.org/group/fairgroup/fairprinciples). All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. Authors will be required to confirm adherence to the policy. If you cannot share the data described in your manuscript, for example for legal or ethical reasons, or do not intend to share the data then you must provide the appropriate data availability statement. Veterinary and Comparative Oncology notes that FAIR data sharing allows for access to shared data under restrictions (e.g., to protect confidential or proprietary information) but notes that the FAIR principles encourage you to share data in ways that are as open as possible (but that can be as closed as necessary). Sample statements are available here. If published, all statements will be placed in the heading of your manuscript.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/14765829/homepage/forauthors.html
